期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
明目-11及其活性成分治疗糖尿病性黄斑水肿的研究进展 被引量:2
1
作者 冉琳琳 苏日古嘎 +1 位作者 陈文林 晓琴 《国际眼科杂志》 CAS 北大核心 2022年第12期1987-1991,共5页
糖尿病性黄斑水肿(DME)是糖尿病威胁视力的一种眼部并发症,是成人失明的重要原因。当前,中国有糖尿病患者1.41亿,伴随糖尿病患病人数的增长,DME的发病率也在逐年攀升。现代医学对DME的治疗取得了一定效果,但副作用明显,且有局限性。明目... 糖尿病性黄斑水肿(DME)是糖尿病威胁视力的一种眼部并发症,是成人失明的重要原因。当前,中国有糖尿病患者1.41亿,伴随糖尿病患病人数的增长,DME的发病率也在逐年攀升。现代医学对DME的治疗取得了一定效果,但副作用明显,且有局限性。明目-11是我院眼科临床应用较为广泛的治疗糖尿病视网膜病变的有效方剂,包含了藏花醛、藏红花酸、姜黄素、没食子酸、鞣花酸、山奈酚、香草醛等生物活性成分。明目-11相关实验研究和临床应用报告显示,该药对DME的神经损害、缺血再灌注损伤、炎症、氧化损伤、微血管损害及渗漏等具有保护作用,可延缓糖尿病视网膜病变(DR)的进展。本文从DME的发病机制、明目-11及其活性成分对DME的治疗作用等方面进行论述。 展开更多
关键词 民族医学 明目-11 糖尿病性黄斑水肿 藏红花 姜黄素
下载PDF
Inhibitory effects of safranal on laser-induced choroidal neovascularization and human choroidal microvascular endothelial cells and related pathways analyzed with transcriptome sequencing 被引量:1
2
作者 Qin-Xiao Yao-Yao Sun +9 位作者 Zhan-Jun Lu Tian-Zi Zhang Shan-Shan Li Ting Hua Suriguga wen-lin chen Lin-Lin Ran Wen-Zhen Yu Fei Yang Burenbatu 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2021年第7期981-989,共9页
AIM:To determine the effects of safranal on choroidal neovascularization(CNV)and oxidative stress damage of human choroidal microvascular endothelial cells(HCVECs)and its possible mechanisms.METHODS:Forty-five rats we... AIM:To determine the effects of safranal on choroidal neovascularization(CNV)and oxidative stress damage of human choroidal microvascular endothelial cells(HCVECs)and its possible mechanisms.METHODS:Forty-five rats were used as a laser-induced CNV model for testing the efficacy and safety of safranal(0.5 mg/kg·d,intraperitoneally)on CNV.CNV leakage on fluorescein angiography(FA)and CNV thickness on histology was compared.HCVECs were used for a H_(2)O_(2)-induced oxidative stress model to test the effect of safranal in vitro.MTT essay was carried to test the inhibition rate of safranal on cell viability at different concentrations.Tube formation was used to test protective effect of safranal on angiogenesis at different concentrations.mRNA transcriptome sequencing was performed to find the possible signal pathway.The expressions of different molecules and their phosphorylation level were validated by Western blotting.RESULTS:On FA,the average CNV leakage area was 0.73±0.49 and 0.31±0.11 mm^(2)(P=0.012)in the control and safranal-treated group respectively.The average CNV thickness was 127.4±18.75 and 100.6±17.34μm(P=0.001)in control and safranal-treated group.Under the condition of oxidative stress,cell proliferation was inhibited by safranal and inhibition rates were 7.4%-35.4%at the different concentrations.For tube formation study,the number of new branches was 364 in control group and 35,42,and 17 in 20,40,and 80μg/mL safranal groups respectively(P<0.01).From the KEGG pathway bubble graph,the PI3K-AKT signaling pathway showed a high gene ratio.The protein expression was elevated of insulin receptor substrate(IRS)and the phosphorylation level of PI3K,phosphoinositide-dependent protein kinase 1/2(PDK1/2),AKT and Bcl-2 associated death promoter(BAD)was also elevated under oxidative stress condition but inhibited by safranal.CONCLUSION:Safranal can inhibit CNV both in vivo and in vitro,and the IRS-PI3K-PDK1/2-AKT-BAD signaling pathway is involved in the pathogenesis of CNV. 展开更多
关键词 choroidal neovascularization safranal human choroidal microvascular endothelial cells oxidative stress TRANSCRIPTOMICS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部